280 related articles for article (PubMed ID: 6309886)
1. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
[TBL] [Abstract][Full Text] [Related]
2. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents.
Chen TL; Hirst MA; Cone CM; Hochberg Z; Tietze HU; Feldman D
J Clin Endocrinol Metab; 1984 Sep; 59(3):383-8. PubMed ID: 6086691
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
[TBL] [Abstract][Full Text] [Related]
5. Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone.
Liberman UA; Eil C; Holst P; Rosen JF; Marx SJ
J Clin Endocrinol Metab; 1983 Nov; 57(5):958-62. PubMed ID: 6311866
[TBL] [Abstract][Full Text] [Related]
6. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
Griffin JE; Zerwekh JE
J Clin Invest; 1983 Oct; 72(4):1190-9. PubMed ID: 6313754
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
Gamblin GT; Liberman UA; Eil C; Downs RW; DeGrange DA; Marx SJ
J Clin Invest; 1985 Mar; 75(3):954-60. PubMed ID: 3872316
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid.
Hirst MA; Hochman HI; Feldman D
J Clin Endocrinol Metab; 1985 Mar; 60(3):490-5. PubMed ID: 2982898
[TBL] [Abstract][Full Text] [Related]
9. [Vitamin D-resistant rickets type II: apropos of 2 cases].
Simonin G; Chabrol B; Moulene E; Bollini G; Strouc S; Mattei JF; Giraud F
Pediatrie; 1992; 47(12):817-20. PubMed ID: 1338926
[TBL] [Abstract][Full Text] [Related]
10. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor.
Zhu W; Malloy PJ; Delvin E; Chabot G; Feldman D
J Bone Miner Res; 1998 Feb; 13(2):259-64. PubMed ID: 9495519
[TBL] [Abstract][Full Text] [Related]
11. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II.
Malloy PJ; Hochberg Z; Pike JW; Feldman D
J Clin Endocrinol Metab; 1989 Feb; 68(2):263-9. PubMed ID: 2537329
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3.
Feldman D; Chen T; Cone C; Hirst M; Shani S; Benderli A; Hochberg Z
J Clin Endocrinol Metab; 1982 Nov; 55(5):1020-2. PubMed ID: 6288751
[TBL] [Abstract][Full Text] [Related]
13. Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy.
Takeda E; Yokota I; Kawakami I; Hashimoto T; Kuroda Y; Arase S
Eur J Pediatr; 1989 Oct; 149(1):54-7. PubMed ID: 2558018
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM; Hirst MA; Feldman D
Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
[TBL] [Abstract][Full Text] [Related]
16. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.
Koren R; Ravid A; Liberman UA; Hochberg Z; Weisman Y; Novogrodsky A
J Clin Invest; 1985 Nov; 76(5):2012-5. PubMed ID: 2997300
[TBL] [Abstract][Full Text] [Related]
17. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy.
Sakati N; Woodhouse NJ; Niles N; Harfi H; de Grange DA; Marx S
Horm Res; 1986; 24(4):280-7. PubMed ID: 3023230
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
Beer S; Tieder M; Kohelet D; Liberman OA; Vure E; Bar-Joseph G; Gabizon D; Borochowitz ZU; Varon M; Modai D
Clin Endocrinol (Oxf); 1981 Apr; 14(4):395-402. PubMed ID: 6266702
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D.
Marx SJ; Bliziotes MM; Nanes M
Clin Endocrinol (Oxf); 1986 Oct; 25(4):373-81. PubMed ID: 3040300
[TBL] [Abstract][Full Text] [Related]
20. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
